{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T02:27:45Z","timestamp":1690511265374},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T00:00:00Z","timestamp":1441238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T00:00:00Z","timestamp":1441238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Decoy receptor 3 (DcR3) expression in kidneys has been shown to predict progression of chronic kidney disease. We prospectively investigated a cohort comprising 96 renal transplant recipients (RTRs) undergoing graft kidney biopsies. Computer-assisted quantitative immunohistochemical staining value of DcR3 in renal tubular epithelial cells (RTECs) was used to determine the predictive role of DcR3 in kidney disease progression. The primary end point was doubling of serum creatinine and\/or graft failure. A multivariate Cox proportional hazards model was used to assess the risk of DcR3 expression in rejected kidney grafts toward the renal end point. In total, RTRs with kidney allograft rejection were evaluated and the median follow-up was 30.9 months. The greater expression of DcR3 immunoreactivity in RTECs was correlated with a higher rate of the histopathological concordance of acute T cell-mediated rejection. Compared with 65 non-progressors, 31 progressors had higher DcR3 expression (HDE) regardless of the traditional risk factors. Cox regression analysis showed HDE was significantly associated with the risk of renal end point with a hazard ratio of 3.19 (95% confidence interval, 1.40 to 7.27; P\u2009=\u20090.006) after adjusting for other variables. In repetitive biopsies, HDE in tissue showed rapid kidney disease progression due to persistent inflammation.<\/jats:p>","DOI":"10.1038\/srep12769","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T09:50:57Z","timestamp":1441273857000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Expression of decoy receptor 3 in kidneys is associated with allograft survival after kidney transplant rejection"],"prefix":"10.1038","volume":"5","author":[{"given":"Shuo-Chun","family":"Weng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Hsiung","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Ju","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Chin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shie-Liang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nien-Jung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Der-Cherng","family":"Tarng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,3]]},"reference":[{"key":"BFsrep12769_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1053\/j.ajkd.2006.10.018","volume":"49","author":"ES Baskin-Bey","year":"2007","unstructured":"Baskin-Bey, E. S., Kremers, W. & Nyberg, S. L. A recipient risk score for deceased donor renal allocation. Am. J. Kidney Dis. 49, 284\u2013293 (2007).","journal-title":"Am. J. Kidney Dis."},{"key":"BFsrep12769_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1034\/j.1600-6143.2003.00111.x","volume":"3","author":"SL Nyberg","year":"2003","unstructured":"Nyberg, S. L. et al. Improved scoring system to assess adult donors for cadaver renal transplantation. Am. J. Transplant. 3, 715\u2013721 (2003).","journal-title":"Am. J. Transplant."},{"key":"BFsrep12769_CR3","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMra0902927","volume":"363","author":"BJ Nankivell","year":"2010","unstructured":"Nankivell, B. J. & Alexander, S. I. Rejection of the kidney allograft. N. Engl. J. Med. 363, 1451\u20131462 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep12769_CR4","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/j.1600-6143.2008.02268.x","volume":"8","author":"S Bunnag","year":"2008","unstructured":"Bunnag, S. et al. FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am. J. Transplant. 8, 1423\u20131433 (2008).","journal-title":"Am. J. Transplant."},{"key":"BFsrep12769_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1600-6143.2008.02462.x","volume":"9","author":"M Mengel","year":"2009","unstructured":"Mengel, M. et al. Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts. Am. J. Transplant. 9, 169\u2013178 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFsrep12769_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/TP.0b013e31823cab44","volume":"93","author":"KJ Wood","year":"2012","unstructured":"Wood, K. J. & Goto, R. Mechanisms of rejection: current perspectives. Transplantation 93, 1\u201310 (2012).","journal-title":"Transplantation"},{"key":"BFsrep12769_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/25387","volume":"396","author":"RM Pitti","year":"1998","unstructured":"Pitti, R. M. et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396, 699\u2013703 (1998).","journal-title":"Nature"},{"key":"BFsrep12769_CR8","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1172\/JCI12159","volume":"107","author":"J Zhang","year":"2001","unstructured":"Zhang, J. et al. Modulation of T-cell responses to alloantigens by TR6\/DcR3. J. Clin. Invest. 107, 1459\u20131468 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFsrep12769_CR9","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1073\/pnas.97.3.1230","volume":"97","author":"C Bai","year":"2000","unstructured":"Bai, C. et al. Overexpression of M68\/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc. Natl. Acad. Sci. USA. 97, 1230\u20131235 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BFsrep12769_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s101200200011","volume":"5","author":"Y Takahama","year":"2002","unstructured":"Takahama, Y. et al. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas. Gastric Cancer 5, 61\u201368 (2002).","journal-title":"Gastric Cancer"},{"key":"BFsrep12769_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jim.2003.11.004","volume":"285","author":"J Chen","year":"2004","unstructured":"Chen, J., Zhang, L. & Kim, S. Quantification and detection of DcR3, a decoy receptor in the TNFR family. J. Immunol. Methods 285, 63\u201370 (2004).","journal-title":"J. Immunol. Methods"},{"key":"BFsrep12769_CR12","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/modpathol.2013.29","volume":"26","author":"WC Tseng","year":"2013","unstructured":"Tseng, W. C., Yang, W. C., Yang, A. H., Hsieh, S. L. & Tarng, D. C. Expression of TNFRSF6B in kidneys is a novel predictor for progression of chronic kidney disease. Mod. Pathol. 26, 984\u2013994 (2013).","journal-title":"Mod. Pathol."},{"key":"BFsrep12769_CR13","first-page":"162","volume":"114","author":"L Cheng","year":"2001","unstructured":"Cheng, L. & Chen, Y. Anti-Fas antibody induces apoptosis in cultured human renal interstitial fibroblasts. Chin. Med. J. (Engl) 114, 162\u2013166 (2001).","journal-title":"Chin. Med. J. (Engl)"},{"key":"BFsrep12769_CR14","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1681\/ASN.2006111242","volume":"18","author":"SM Ka","year":"2007","unstructured":"Ka, S. M. et al. Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritis model in mice. J. Am. Soc. Nephrol. 18, 2473\u20132485 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFsrep12769_CR15","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bcp.2011.01.011","volume":"81","author":"WW Lin","year":"2011","unstructured":"Lin, W. W. & Hsieh, S. L. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer. Biochem. Pharmacol. 81, 838\u2013847 (2011).","journal-title":"Biochem. Pharmacol."},{"key":"BFsrep12769_CR16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/01.tp.0000199266.07237.25","volume":"81","author":"K Kawamoto","year":"2006","unstructured":"Kawamoto, K. et al. Significant inhibition of human CD8(+) cytotoxic T lymphocyte-mediated xenocytotoxicity by overexpression of the human decoy Fas antigen. Transplantation 81, 789\u2013796 (2006).","journal-title":"Transplantation"},{"key":"BFsrep12769_CR17","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/labinvest.3780364","volume":"81","author":"RS Al-Lamki","year":"2001","unstructured":"Al-Lamki, R. S. et al. Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab. Invest. 81, 1503\u20131515 (2001).","journal-title":"Lab. Invest."},{"key":"BFsrep12769_CR18","unstructured":"John, V. Risk factors for graft failure in kidney transplantation. Wolters Kluwer: Gordon Guyatt, McMaster University (2012) Available at: http:\/\/optn.transplant.hrsa.gov\/SharedContentDocuments\/KidneyConceptDocument.PDF. (Accessed: 17th November 2014)"},{"key":"BFsrep12769_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.trre.2008.02.005","volume":"22","author":"ES Baskin-Bey","year":"2008","unstructured":"Baskin-Bey, E. S. & Nyberg, S. L. Matching graft to recipient by predicted survival: can this be an acceptable strategy to improve utilization of deceased donor kidneys? Transplant. Rev. (Orlando) 22, 167\u2013170 (2008).","journal-title":"Transplant. Rev. (Orlando)"},{"key":"BFsrep12769_CR20","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1053\/j.ajkd.2008.02.308","volume":"51","author":"CA White","year":"2008","unstructured":"White, C. A., Huang, D., Akbari, A., Garland, J. & Knoll, G. A. Performance of creatinine-based estimates of GFR in kidney transplant recipients: a systematic review. Am. J. Kidney Dis. 51, 1005\u20131015 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"BFsrep12769_CR21","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1084\/jem.20031939","volume":"199","author":"HH Sung","year":"2004","unstructured":"Sung, H. H. et al. Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. J. Exp. Med. 199, 1143\u20131151 (2004).","journal-title":"J. Exp. Med."},{"key":"BFsrep12769_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.clim.2005.02.014","volume":"115","author":"S Kim","year":"2005","unstructured":"Kim, S., Fotiadu, A. & Kotoula, V. Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia. Clin. Immunol. 115, 286\u2013294 (2005).","journal-title":"Clin. Immunol."},{"key":"BFsrep12769_CR23","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.bbadis.2013.05.020","volume":"1832","author":"NL Wu","year":"2013","unstructured":"Wu, N. L. el al. EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis. Biochim. Biophys. Acta. 1832, 1538\u20131548 (2013).","journal-title":"Biochim. Biophys. Acta."},{"key":"BFsrep12769_CR24","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2215\/CJN.08410811","volume":"7","author":"SC Hung","year":"2012","unstructured":"Hung, S. C., Hsu, T. W., Lin, Y. P. & Tarng, D. C. Decoy receptor 3, a novel inflammatory marker and mortality in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 7, 1257\u20131265 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFsrep12769_CR25","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.4049\/jimmunol.174.3.1647","volume":"174","author":"CR Yang","year":"2005","unstructured":"Yang, C. R., Hsieh, S. L., Ho, F. M. & Lin, W. W. Decoy receptor 3 increases monocyte adhesion to endothelial cells via NF-kappa B-dependent up-regulation of intercellular adhesion molecule-1, VCAM-1 and IL-8 expression. J. Immunol. 174, 1647\u20131656 (2005).","journal-title":"J. Immunol."},{"key":"BFsrep12769_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1359-6101(03)00031-5","volume":"14","author":"SW Granger","year":"2003","unstructured":"Granger, S. W. & Rickert, S. LIGHT-HVEM signaling and the regulation of T cell-mediated immunity. Cytokine Growth Factor Rev. 14, 289\u2013296 (2003).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFsrep12769_CR27","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1182\/blood-2007-12-130609","volume":"111","author":"YC Chang","year":"2008","unstructured":"Chang, Y. C. et al. Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3. Blood 111, 5054\u20135063 (2008).","journal-title":"Blood"},{"key":"BFsrep12769_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ajt.12590","volume":"14","author":"M Haas","year":"2014","unstructured":"Haas, M. et al. Banff meeting report writing committee: Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am. J. Transplant. 14, 272\u2013283 (2014).","journal-title":"Am. J. Transplant."},{"key":"BFsrep12769_CR29","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1681\/ASN.2004060475","volume":"16","author":"F Ortiz","year":"2005","unstructured":"Ortiz, F. et al. Predictors of renal allograft histologic damage progression. J. Am. Soc. Nephrol. 16, 817\u2013824 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFsrep12769_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/002215540305100209","volume":"51","author":"KA Matkowskyj","year":"2003","unstructured":"Matkowskyj, K. A., Cox, R., Jensen, R. T. & Benya, R. V. Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures receptor number. J. Histochem. Cytochem. 51, 205\u2013214 (2003).","journal-title":"J. Histochem. Cytochem."},{"key":"BFsrep12769_CR31","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1111\/j.1600-6143.2010.03267.x","volume":"10","author":"PF Halloran","year":"2010","unstructured":"Halloran, P. F. et al. The molecular phenotype of kidney transplants. Am. J. Transplant. 10, 2215\u20132222 (2010).","journal-title":"Am. J. Transplant."},{"key":"BFsrep12769_CR32","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","volume":"367","author":"HH Parving","year":"2012","unstructured":"Parving, H. H. et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N. Engl. J. Med. 367, 2204\u20132213 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep12769_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1681\/ASN.2012080777","volume":"24","author":"HN Ibrahim","year":"2013","unstructured":"Ibrahim, H. N. et al. Angiotensin II blockade in kidney transplant recipients. J. Am. Soc. Nephrol. 24, 320\u2013327 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFsrep12769_CR34","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","volume":"10","author":"B Sis","year":"2010","unstructured":"Sis, B. et al. Banff \u201809 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am. J. Transplant. 10, 464\u2013471 (2010).","journal-title":"Am. J. Transplant."},{"key":"BFsrep12769_CR35","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.2353\/ajpath.2010.090539","volume":"176","author":"YH Hsu","year":"2010","unstructured":"Hsu, Y. H. et al. Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7. Am. J. Pathol. 176, 3050\u20133061 (2010).","journal-title":"Am. J. Pathol."},{"key":"BFsrep12769_CR36","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/ki.2014.205","volume":"86","author":"TH Lo","year":"2014","unstructured":"Lo, T. H. et al. TREM-1 regulates macrophage polarization in ureteral obstruction. Kidney Int. 86, 1174\u20131186 (2014).","journal-title":"Kidney Int."},{"key":"BFsrep12769_CR37","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.dld.2008.11.019","volume":"41","author":"S Kim","year":"2009","unstructured":"Kim, S., Kotoula, V., Hytiroglou, P., Zardavas, D., Zhang, L. Significance of increased expression of decoy receptor 3 in chronic liver disease. Dig. Liver Dis. 41, 591\u2013598 (2009).","journal-title":"Dig. Liver Dis."},{"key":"BFsrep12769_CR38","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1172\/JCI41789","volume":"120","author":"G Einecke","year":"2010","unstructured":"Einecke, G. et al. A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J. Clin. Invest. 120, 1862\u20131872 (2010).","journal-title":"J. Clin. Invest."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep12769","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep12769.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep12769.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T21:57:04Z","timestamp":1672955824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep12769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,3]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,10,16]]}},"alternative-id":["BFsrep12769"],"URL":"https:\/\/doi.org\/10.1038\/srep12769","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,3]]},"assertion":[{"value":"9 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12769"}}